| __timestamp | Protagonist Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 55430000 |
| Thursday, January 1, 2015 | 11831000 | 65510000 |
| Friday, January 1, 2016 | 25705000 | 71160000 |
| Sunday, January 1, 2017 | 46181000 | 70644000 |
| Monday, January 1, 2018 | 59497000 | 70418000 |
| Tuesday, January 1, 2019 | 65003000 | 63238000 |
| Wednesday, January 1, 2020 | 74506000 | 59777000 |
| Friday, January 1, 2021 | 126006000 | 60152000 |
| Saturday, January 1, 2022 | 126215000 | 54540000 |
| Sunday, January 1, 2023 | 120161000 | 52243000 |
| Monday, January 1, 2024 | 64536000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Protagonist Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. have been on a fascinating journey over the past decade.
From 2014 to 2023, Protagonist Therapeutics has shown a remarkable increase in R&D spending, growing by over 1,500%. This surge reflects their commitment to pioneering new treatments and therapies. Notably, their R&D expenses peaked in 2022, highlighting a strategic push towards innovation.
In contrast, Taro Pharmaceutical's R&D spending has remained relatively stable, with a slight decline of around 10% from 2014 to 2023. This steady approach suggests a focus on optimizing existing products rather than aggressive expansion.
As we look to the future, the differing strategies of these two companies will undoubtedly shape their trajectories in the pharmaceutical landscape.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
R&D Insights: How Novo Nordisk A/S and Taro Pharmaceutical Industries Ltd. Allocate Funds
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Vericel Corporation vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds